Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |